FTC alleges no actual harm, Qualcomm says

The Federal Trade Commission’s suit against Qualcomm for its patent licensing practices does not allege a plausible antitrust theory, the technology company asserted this week in its motion to dismiss, echoing statements made by the agency’s acting head Maureen Ohlhausen.

Get unlimited access to all Global Competition Review content